Osteoid, founded in 2014, is revolutionizing the field of medical devices with its innovative approach to orthopedic braces. Operating out of Turkey, the company leverages advanced 3D printing technology to offer customized solutions, addressing a crucial need in the orthosis industry.
The company's slogan, "Custom orthopedic braces crafted using advanced 3D printing technology," encapsulates its mission to push the boundaries of conventional orthosis by integrating therapeutic and monitoring technologies. This futuristic vision positions Osteoid as a potential game-changer in the medical devices sector.
Their last recorded funding was a Venture Round investment on 01 November 2015, spearheaded by investor Vestel Ventures. While this reflects valuable early-stage confidence, a proactive engagement with new investors could be crucial for fueling future growth. Osteoid presents an enticing opportunity for investors looking to back technology-driven healthcare innovations.